EBS vs MCD · rev $1.04B vs P/E 23, rev $25.92B
Emergent Biosolutions Inc (EBS) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
EBS currently screens at market cap $416.4M. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the EBS and MCD stock pages for the full models.
Not investment advice.